期刊
NATURE REVIEWS CANCER
卷 9, 期 6, 页码 415-428出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2644
关键词
-
类别
资金
- Anderson Ovarian SPORE National Cancer Institutes [P50CA83639]
- National Foundation for Cancer Research
- Ovarian Cancer Research Fund
- Mossy Foundation
- Zarrow Foundation
Over the past two decades, the 5-year survival for ovarian cancer patients has substantially improved owing to more effective surgery and treatment with empirically optimized combinations of cytotoxic drugs, but the overall cure rate remains approximately 30%. Many investigators think that further empirical trials using combinations of conventional agents are likely to produce only modest incremental improvements in outcome. Given the heterogeneity of this disease, increases in long-term survival might be achieved by translating recent insights at the molecular and cellular levels to personalize individual strategies for treatment and to optimize early detection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据